Pharmacological inhibition of the chemokine C-C motif chemokine ligand 2 (monocyte chemoattractant protein 1) accelerates liver fibrosis regression by suppressing Ly-6C+ macrophage infiltration in mice

Cited by (271)

Items 101–200 of 271

1. Antifibrotics in chronic liver disease: tractable targets and translational challenges
   Prakash Ramachandran, Neil Cowan Henderson · 2016 · The Lancet. Gastroenterology & hepatology
2. Targeting GPR65 alleviates hepatic inflammation and fibrosis by suppressing the JNK and NF-κB pathways
   Kun Zhang, Mengxia Zhang, Xiao-Xiang Meng, Jing Zhu, Jia-Jun Wang, Yifan He, Yehua Li, Sicong Zhao, Zhemin Shi, Lina Zheng et al. · 2023 · Military Medical Research
3. Exosomes from adipose-derived stem cells accelerate wound healing by increasing the release of IL-33 from macrophages
   Yichen Wang, Hongfan Ding, Ruiqi Bai, Qiang Li, Boyuan Ren, Pianpian Lin, Chengfei Li, Minliang Chen, Xiao Xu · 2025 · Stem Cell Research & Therapy
4. CD5L is a pleiotropic player in liver fibrosis controlling damage, fibrosis and immune cell content
   Cristina Bárcena, Gemma Aran, Luís Perea, Lucía Sanjurjo, Érica Téllez, Anna Oncins, Helena Masnou, Isabel Serra, Mónica Garcı́a-Gallo, Leonor Kremer et al. · 2019 · EBioMedicine
5. Role of the chemokine system in liver fibrosis: a narrative review
   Kyle L. Poulsen, Christina K. Cajigas‐Du Ross, Jarod Chaney, Laura E. Nagy · 2022 · Digestive Medicine Research
6. Placental Growth Factor Contributes to Liver Inflammation, Angiogenesis, Fibrosis in Mice by Promoting Hepatic Macrophage Recruitment and Activation
   Xi Li, Qianwen Jin, Qunyan Yao, Yi Zhou, Yanting Zou, Zheng Li, Shuncai Zhang, Chuantao Tu · 2017 · Frontiers in Immunology
7. Targeting CCR2/5 in the treatment of nonalcoholic steatohepatitis (NASH) and fibrosis: opportunities and challenges
   Lefere, Sander, Devisscher, Lindsey, Tacke, Frank · 2020 · Expert Opinion on Investigational Drugs
8. Curcumin reduces Ly6Chi monocyte infiltration to protect against liver fibrosis by inhibiting Kupffer cells activation to reduce chemokines secretion
   Xiang‐An Zhao, Guangmei Chen, Yong Liu, Yuxin Chen, Hongyan Wu, Yali Xiong, Guiyang Wang, Bei Jia, Yang Li, Juan Xia et al. · 2018 · Biomedicine & Pharmacotherapy
9. Macrophages in Chronic Liver Failure: Diversity, Plasticity and Therapeutic Targeting
   Arjuna Singanayagam, Evangelos Triantafyllou · 2021 · Frontiers in Immunology
10. The receptor tyrosine kinase EphB2 promotes hepatic fibrosis in mice
    Patrice Nsangou Mimche, Lauren M. Brady, Christian Bray, Choon M. Lee, Manoj Thapa, Thayer King, Kendra M. Quicke, Courtney D. McDermott, Sylvie M. Mimche, Arash Grakoui et al. · 2015 · Hepatology
11. The diversity of myeloid immune cells shaping wound repair and fibrosis in the lung
    Laura Florez‐Sampedro, Shanshan Song, Barbro N. Melgert · 2018 · Regeneration
12. Systemic MCP-1 Levels Derive Mainly From Injured Liver and Are Associated With Complications in Cirrhosis
    Alexander Queck, Hannah Bode, Frank Erhard Uschner, Maximilian Joseph Brol, Christiana Graf, Martin Sebastian Schulz, Christian Jansen, Michael Praktiknjo, Robert Schierwagen, Sabine Klein et al. · 2020 · Frontiers in Immunology
13. The Gut–Liver Axis in Chronic Liver Disease: A Macrophage Perspective
    Kevin De Muynck, Bart Vanderborght, Hans Van Vlierberghe, Lindsey Devisscher · 2021 · Cells
14. Update on implications and mechanisms of angiogenesis in liver fibrosis
    Zili Zhang, Feng Zhang, Yin Lu, Shizhong Zheng · 2014 · Hepatology Research
15. The role of macrophages in obesity-driven chronic liver disease
    Lindsey Devisscher, Xavier Verhelst, Isabelle O. Colle, Hans Van Vlierberghe, Anja M. Geerts · 2016 · Journal of Leukocyte Biology
16. Loss of hepatocyte cell division leads to liver inflammation and fibrosis
    Dewhurst, Matthew R., Ow, Jin Rong, Zafer, Gözde, van Hul, Noémi K. M., Wollmann, Heike, Bisteau, Xavier, Brough, David, Choi, Hyungwon, Kaldis, Philipp · 2020 · PLOS Genetics
17. The immunomodulatory quinoline-3-carboxamide paquinimod reverses established fibrosis in a novel mouse model for liver fibrosis
    Nina Fransén-Pettersson, Adnan Deronic, Julia Nilsson, Tine Dahlbaek Hannibal, Lisbeth Hansen, Anja Schmidt-Christensen, Fredrik Ivars, Dan Holmberg · 2018 · PLoS ONE
18. Regulation of Hepatic Inflammation via Macrophage Cell Death
    Zhuan Li, Steven A. Weinman · 2018 · Seminars in Liver Disease
19. New Pharmacologic Agents That Target Inflammation and Fibrosis in Nonalcoholic Steatohepatitis–Related Kidney Disease
    Giovanni Musso, Franco De Michieli, Daria Bongiovanni, Renato Parente, Luciana Framarin, Nicola Leone, Mara Berrutti, Roberto Gambino, Maurizio Cassader, Solomon J. Cohney et al. · 2016 · Clinical Gastroenterology and Hepatology
20. Toll-like receptor-2 regulates macrophage polarization induced by excretory-secretory antigens from Schistosoma japonicum eggs and promotes liver pathology in murine schistosomiasis
    Wenci Gong, Fengjuan Huang, Lei Sun, Aiping Yu, Xiaofan Zhang, Yuxin Xu, Yujuan Shen, Jianping Cao · 2018 · PLoS neglected tropical diseases
21. Liver Fibrosis—From Mechanisms of Injury to Modulation of Disease
    Christian Liedtke, Yulia Alexandrowna Nevzorova, Tom Luedde, Henning Wolfgang Zimmermann, Daniela C. Kroy, Pavel Strnad, Marie‐Luise Berres, Jürgen Bernhagen, Frank Tacke, Jacob Nattermann et al. · 2022 · Frontiers in Medicine
22. Tianhuang formula ameliorates liver fibrosis by inhibiting CCL2-CCR2 axis and MAPK/NF-κB signaling pathway
    Tian Lan, Bo Chen, Xianzhe Hu, Jiafan Cao, Shiyun Chen, Xin Ding, Shengwen Li, Yanfang Fu, Huanle Liu, Duosheng Luo et al. · 2023 · Journal of Ethnopharmacology
23. CCL2–CCR2 signaling promotes hepatic ischemia/reperfusion injury
    Junbin Zhang, Peng Xu, Peng Song, Hui Wang, Yong Zhang, Qinggang Hu, Guoliang Wang, Shu Zhang, Qilin Yu, Timothy R. Billiar et al. · 2016 · Journal of Surgical Research
24. Red blood cell-derived nanovesicles for safe and efficient macrophage-targeted drug delivery in vivo
    Xue Wan, Shi Zhang, Feng Wang, Wei Fan, Chenxi Wu, Kuirong Mao, Hongda Wang, Zheng Hu, Yong‐Guang Yang, Tianmeng Sun · 2018 · Biomaterials Science
25. Disruption of myofibroblastic Notch signaling attenuates liver fibrosis by modulating fibrosis progression and regression
    Zhen‐Sheng Yue, Zijian Jiang, Bai Ruan, Juanli Duan, Ping Song, Jingjing Liu, Hua Han, Lin Wang · 2021 · International Journal of Biological Sciences
26. Peroxidasin Deficiency Re-programs Macrophages Toward Pro-fibrolysis Function and Promotes Collagen Resolution in Liver
    Sojoodi, Mozhdeh, Erstad, Derek J., Barrett, Stephen C., Salloum, Shadi, Zhu, Shijia, Qian, Tongqi, Colon, Selene, Gale, Eric M., Jordan, Veronica Clavijo, Wang, Yongtao et al. · 2022 · Cellular and Molecular Gastroenterology and Hepatology
27. Vaccination-based immunotherapy to target profibrotic cells in liver and lung
    Michal Sobecki, Jing Chen, Ewelina Krzywińska, Shunmugam Nagarajan, Zheng Fan, Eric Nelius, Josep M. Monné Rodríguez, Frauke Seehusen, Amro Hussein, Greta Moschini et al. · 2022 · Cell stem cell
28. Impact of myeloid-derived suppressor cell on Kupffer cells from mouse livers with hepatocellular carcinoma
    Stéphanie Lacotte, Florence Slits, Lorenzo A. Orci, Jérémy Meyer, Graziano Oldani, Vaihere Delaune, Carmen Gonelle‐Gispert, Philippe Morel, Christian Toso · 2016 · OncoImmunology
29. Function and therapeutic advances of chemokine and its receptor in nonalcoholic fatty liver disease
    Wei Chen, Jing Zhang, Hui‐Ning Fan, Jin‐Shui Zhu · 2018 · Therapeutic Advances in Gastroenterology
30. C-C motif chemokine receptor 2 inhibition reduces liver fibrosis by restoring the immune cell landscape
    Yangkun Guo, Chong Zhao, Wenting Dai, Bowen Wang, Enjiang Lai, Yang Xiao, Chengwei Tang, Zhiyin Huang, Jinhang Gao · 2023 · International Journal of Biological Sciences
31. A long-acting LEAP2 analog reduces hepatic steatosis and inflammation and causes marked weight loss in mice
    Kripa Shankar, Nathan P. Metzger, Connor Lawrence, Deepali Gupta, Sherri L. Osborne-Lawrence, Salil Varshney, Omprakash Singh, Corine P. Richard, Alexander N. Zaykov, Rebecca Rolfts et al. · 2024 · Molecular Metabolism
32. Potential Role of Macrophage Phenotypes and CCL2 in the Pathogenesis of Takayasu Arteritis
    Xiufang Kong, Ming Xu, Xiaomeng Cui, Lingying Ma, Huiyong Cheng, Jun Hou, Xiaoning Sun, Lili Ma, Lindi Jiang · 2021 · Frontiers in Immunology
33. Balance of inflammatory pathways and interplay of immune cells in the liver during homeostasis and injury
    Christer Baeck, Frank Tacke · 2014 · Europe PMC (PubMed Central)
34. Kupffer cells mediate the recruitment of hepatic stellate cells into the localized liver damage
    Nasir Abbas, Anteneh Getachew, Kai You, Zahir Shah, Yan Chen, Jiawang Tao, Muzammal Hussain, Fan Yang, Yuanqi Zhuang, Yingying Xu et al. · 2020 · Biochemical and Biophysical Research Communications
35. Tetrastigma hemsleyanum leaf extracts ameliorate NAFLD in mice with low-grade colitis via the gut–liver axis
    Lihua Xiao, Hua Xiong, Zeyuan Deng, Xin Xiang Peng, Kejun Cheng, Hua Zhang, Li Jiang, Yong Sun · 2022 · Food & Function
36. Development of Capsular Fibrosis Beneath the Liver Surface in Humans and Mice
    Steven Balog, Yuchang Li, Tomohiro Ogawa, Toshio Miki, Takeshi Saito, Samuel William French, Kinji Asahina · 2019 · Hepatology
37. Liver fibrosis affects the targeting properties of drug delivery systems to macrophage subsets in vivo
    Ergen, Can, Niemietz, Patricia Maria, Heymann, Felix, Baues, Maike, Gremse, Felix, Pola, Robert, van Bloois, Louis, Storm, Gert, Kiessling, Fabian, Trautwein, Christian et al. · 2019 · Biomaterials
38. Sennoside A alleviates inflammatory responses by inhibiting the hypermethylation of SOCS1 in CCl4-induced liver fibrosis
    Hong Zhu, Huizi Zhao, Songbing Xu, Yuan Zhang, Yuhao Ding, Jun Li, Cheng Huang, Taotao Ma · 2021 · Pharmacological Research
39. MyD88 in Macrophages Enhances Liver Fibrosis by Activation of NLRP3 Inflammasome in HSCs
    Shuang Ge, Wei Ping Yang, Haiqiang Chen, Qi Yuan, Shi Liu, Yongxiang Zhao, Jinhua Zhang · 2021 · International Journal of Molecular Sciences
40. Mesencephalic astrocyte-derived neurotrophic factor reprograms macrophages to ameliorate acetaminophen-induced acute liver injury via p38 MAPK pathway
    Xin Hou, Qi Liu, Yimin Gao, Yong Liang, Huiyuan Xie, Wenting Li, Yuping Zhou, Jun Liu, Lijie Feng, Long Xu et al. · 2022 · Cell Death and Disease
41. Cell‐specific elevation of Runx2 promotes hepatic infiltration of macrophages by upregulating MCP‐1 in high‐fat diet‐induced mice NAFLD
    Li Zhong, Lu Huang, Qian Xue, Chang Liu, Keshu Xu, Wei Shen, Liang Deng · 2019 · Journal of Cellular Biochemistry
42. Endotoxin Inflammatory Action on Cells by Dysregulated-Immunological-Barrier-Linked ROS-Apoptosis Mechanisms in Gut–Liver Axis
    Andrei Dumitru, Elena Matei, Georgeta Camelia Cozaru, Anca Chisoi, Luana Alexandrescu, Razvan Catalin Popescu, Mihaela Butcaru Pundiche, Eugen Dumitru, Sorin Rugină, Cristina Tocia · 2024 · International Journal of Molecular Sciences
43. The role of macrophages in liver fibrosis: composition, heterogeneity, and therapeutic strategies
    Xiaocao Ma, Jia Qiu, Shubiao Zou, Liling Tan, Tingting Miao · 2024 · Frontiers in Immunology
44. Early to Phase II drugs currently under investigation for the treatment of liver fibrosis
    Peter Hauff, Ulrich Gottwald, Matthias Ocker · 2014 · Expert Opinion on Investigational Drugs
45. Inhibiting ATP6V0D2 Aggravates Liver Ischemia-Reperfusion Injury by Promoting NLRP3 Activation via Impairing Autophagic Flux Independent of Notch1/Hes1
    Ziyi Wang, Hao Wang, Xuejiao Chen, Sheng Han, Yulin Zhu, Hanhua Wang, Feng Cheng, Liyong Pu · 2021 · Journal of Immunology Research
46. Increased Sensitivity to Binge Alcohol-Induced Gut Leakiness and Inflammatory Liver Disease in HIV Transgenic Rats
    Atrayee Banerjee, Mohamed A. Abdelmegeed, Sehwan Jang, Byoung‐Joon Song · 2015 · PLoS ONE
47. Emodin Alleviates Liver Fibrosis of Mice by Reducing Infiltration of Gr1hi Monocytes
    Xiang‐An Zhao, Guangmei Chen, Yong Liu, Hongyan Wu, Jin Chen, Yali Xiong, Chen Tian, Bei Jia, Guiyang Wang, Juan Xia et al. · 2018 · Evidence-based Complementary and Alternative Medicine
48. Splenectomy enhances the Ly6Clow phenotype in hepatic macrophages by activating the ERK1/2 pathway during liver fibrosis
    Zhongqiang Zheng, Huan Wang, Liang Li, Shaoying Zhang, Chunyan Zhang, Hailong Zhang, Fanpu Ji, Xi Liu, Kai Zhu, Guangyao Kong et al. · 2020 · International Immunopharmacology
49. B1 cells protect against Schistosoma japonicum–induced liver inflammation and fibrosis by controlling monocyte infiltration
    Yong Liang, Yuanyuan Tang, Cuiping Ren, Miao Liu, Jijia Shen, Xin Hou · 2019 · PLoS neglected tropical diseases
50. Urine Monocyte Chemoattractant Protein-1 Is an Independent Predictive Factor of Hospital Readmission and Survival in Cirrhosis
    Isabel Graupera, Elsa Solà, Núria Fabrellas, Rebeca Moreira, Cristina Solé, Patrícia Huelin, Glòria de Prada, Elisa Pose, Xavier Ariza, Alessandro Risso et al. · 2016 · PLoS ONE
51. Sphingosine Kinase 1 Aggravates Liver Fibrosis by Mediating Macrophage Recruitment and Polarization
    Ding, Xin, Zhang, Xiang, Cao, Jiafan, Chen, Shiyun, Chen, Yinghua, Yuan, Kai, Chen, Bo, Yang, Guizhi, Li, Shengwen, Yang, Jundong et al. · 2024 · Cellular and Molecular Gastroenterology and Hepatology
52. Role of chemokines in aging and age-related diseases
    Jitendra Kumar Chaudhary, Ajay Kumar Danga, Anita Kumari, Akshay Bhardwaj, Pramod C. Rath · 2024 · Mechanisms of Ageing and Development
53. The Biological Function of Kupffer Cells in Liver Disease
    Yuanyuan Ma, Muqing Yang, Zhigang He, Qing Wei, Jiyu Li · 2017 · InTech eBooks
54. Roles of Macrophages in Advanced Liver Fibrosis, Identified Using a Newly Established Mouse Model of Diet-Induced Non-Alcoholic Steatohepatitis
    Yuki Tada, Kaichi Kasai, Nana Makiuchi, Naoya Igarashi, Koudai Kani, Shun Takano, Hiroe Honda, Tsutomu Yanagibashi, Yasuharu Watanabe, Fumitake Usui‐Kawanishi et al. · 2022 · International Journal of Molecular Sciences
55. Function and characteristics of TIM‑4 in immune regulation and disease (Review)
    Ziyao Wang, Chen Chen, Yingzhen Su, Nengwen Ke · 2022 · International Journal of Molecular Medicine
56. Humic Acid and Glucan: Protection Against Liver Injury Induced by Carbon Tetrachloride
    Václav Větvička, José María García‐Mina, Mary Proctor, Jean‐Claude Yvin · 2015 · Journal of Medicinal Food
57. Distinct Hepatic Macrophage Populations in Lean and Obese Mice
    Rafael Mayoral, Andrew M. F. Johnson, Olivia Osborn, Paqui G. Través, Sushil Kumar Mahata · 2016 · Frontiers in Endocrinology
58. Identifying Novel Targets for Treatment of Liver Fibrosis: What Can We Learn from Injured Tissues which Heal Without a Scar?
    Michele T. Pritchard, Jennifer M. McCracken · 2015 · Current Drug Targets
59. Identifying Molecular Factors That Contribute to Resolution of Liver Fibrosis
    John Peter Iredale, Ramon A. Bataller · 2014 · Gastroenterology
60. Liver Regeneration in Chronic Liver Injuries: Basic and Clinical Applications Focusing on Macrophages and Natural Killer Cells
    Yihan Qian, Zhi Shang, Yueqiu Gao, Hailong Wu, Xiaoni Kong · 2022 · Cellular and Molecular Gastroenterology and Hepatology
61. Low-Dose Administration of Cannabigerol Attenuates Inflammation and Fibrosis Associated with Methionine/Choline Deficient Diet-Induced NASH Model via Modulation of Cannabinoid Receptor
    Nouf A. Aljobaily, Kelsey Krutsinger, Michael J. Viereckl, Raznin Joly, Bridger Menlove, Brexton Cone, Ailaina Suppes, Yuyan Han · 2022 · Nutrients
62. Hepatic inflammation elicits production of proinflammatory netrin‐1 through exclusive activation of translation
    Romain Barnault, Claire Verzeroli, Carole Fournier, Maud Michelet, Anna Rita Redavid, Ievgeniia Chicherova, Marie‐Laure Plissonnier, Annie Adrait, Olga A. Khomich, Fleur Chapus et al. · 2022 · Hepatology
63. Intervention of Inflammatory Monocyte Activity Limits Dermal Fibrosis
    Jessica Haub, Nadine Roehrig, Pavel Uhrín, Gernot Schabbauer, Dirk Eulberg, Felix Melchior, Fatemeh Zare Shahneh, Hans Christian Probst, Christian Becker, Kerstin Steinbrink et al. · 2019 · Journal of Investigative Dermatology
64. Comprehensive characterization of metabolic, inflammatory and fibrotic changes in a mouse model of diet-derived nonalcoholic steatohepatitis
    Mi‐Bo Kim, Yoojin Lee, Minkyung Bae, Hyunju Kang, Tho Xuan Pham, Siqi Hu, Ji‐Young Lee, Young‐Ki Park · 2020 · The Journal of Nutritional Biochemistry
65. A conserved pathway of transdifferentiation in murine Kupffer cells
    Xinyu Li, Nicole Hollingshead, Sarah Lampert, Camtu D. Truong, Wanyu Li, Junqi Niu, Ian Nicholas Crispe, Radika Soysa · 2021 · European Journal of Immunology
66. Mitochondria-targeted ROS-scavenging polymer protects the hepatocytes and macrophages against hepatic ischemia-reperfusion injury
    Haitao Hu, Yanpeng Liu, Chang Xu, Jun Chen, Shengjun Xu, Yixiao Tang, Yuhao Ren, Zhengxing Lian, Rui Wang, Siyu Chen et al. · 2025 · Acta Biomaterialia
67. Cardiac Hepatopathy: New Perspectives on Old Problems through a Prism of Endogenous Metabolic Regulations by Hepatokines
    Alexander A. Berezin, Zeljko Obradovic, Tetiana A. Berezina, Elke Boxhammer, Michael Lichtenauer, Alexander Е. Berezin · 2023 · Antioxidants
68. Dually Active Polycation/miRNA Nanoparticles for the Treatment of Fibrosis in Alcohol-Associated Liver Disease
    Chuhan Zhang, Hang Yu, Weimin Tang, Diptesh Sil, Heather C. Jensen‐Smith, Robert G. Bennett, Benita L. McVicker, David Oupický · 2022 · Pharmaceutics
69. TRPM8 deficiency attenuates liver fibrosis through S100A9-HNF4α signaling
    Qiang Liu, Xiaohua Lei, Zhenyu Cao, Ju Zhang, Likun Yan, Jie Fu, Qing Tong, Wei Qin, Yaoli Shao, Chun Liu et al. · 2022 · Cell & Bioscience
70. Comparing the effects of whey and casein supplementation on nutritional status and immune parameters in patients with chronic liver disease: a randomised double-blind controlled trial
    Y. Mizubuti, Érica Leandro Marciano Vieira, Tarcı́lia Aparecida Silva, Michelle Carvalho de Oliveira D’ALESSANDRO, S.V. Generoso, Antônio Lúcio Teixeira, Agnaldo Soares Lima, María Isabel Toulson Davisson Correia · 2020 · British Journal Of Nutrition
71. Immuno-pathomechanism of liver fibrosis: targeting chemokine CCL2-mediated HIV:HCV nexus
    AW Wahid Ansari, Reinhold E. Schmidt, Esaki Muthu Shankar, Adeeba Kamarulzaman · 2014 · Journal of Translational Medicine
72. Ambiguous Pathogenic Roles of Macrophages in Alcohol-Associated Liver Diseases
    Yeni Ait Ahmed, Fouad Lafdil, Frank Tacke · 2023 · Hepatic Medicine Evidence and Research
73. Virus‐Induced Host Chemokine CCL2 in COVID‐19 Pathogenesis: Potential Prognostic Marker and Target of Anti‐Inflammatory Strategy
    Abdul Wahid Ansari, Fareed Ahmad, Majid Ali Alam, Thesni Raheed, Ahmed Zaqout, Muna Almaslamani, Aamir Ahmad, Joerg Buddenkotte, Abdullatif Al‐Khal, Martin S. Steinhoff · 2024 · Reviews in Medical Virology
74. A Review of Liver Fibrosis and Emerging Therapies
    Rooshi Nathwani, Benjamin Harvey Mullish, David Kockerling, Roberta Forlano, Pinelopi Manousou, Ameet Dhar · 2020 · European Medical Journal
75. Liver Macrophage Diversity in Health and Disease
    Paul Horn, Frank Tacke · 2024 · Results and problems in cell differentiation
76. Galectin-1-induced tolerogenic dendritic cells combined with apoptotic lymphocytes prolong liver allograft survival
    Yifan Peng, Yufu Ye, Junjun Jia, Yong He, Zhentao Yang, Xiaolu Zhu, Hechen Huang, Wei Wang, Lei Geng, Shengyong Yin et al. · 2018 · International Immunopharmacology
77. Role of Liver-Mediated Tolerance in Nanoparticle-Based Tumor Therapy
    Maximiliano L. Cacicedo, Carolina Medina‐Montano, Leonard Kaps, Cinja Kappel, Stephan Gehring, Matthias Bros · 2020 · Cells
78. Dynamic crosstalk between HSCs and liver microenvironment: multicellular interactions in the regulation of liver fibrosis
    Luping Wang, Yi Huang, Jingrong Chen, Jialu Gao, Sihan Chen, Mingqi Zhao, Jiguo Lin, Shunqing Zhou, Yan Shen, Yunyun Cheng · 2025 · Frontiers in Cell and Developmental Biology
79. Interactions between hepatic stellate cells and immune cells: Implications for liver fibrosis
    Deyu Xie, Yihui Huang, Yitian Yu, Weikai Jin, Xiangting Zhang, Fujun Yu · 2025 · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
80. Targeting Gut–Liver Axis for Treatment of Liver Fibrosis and Portal Hypertension
    Eric Kalo, Scott A. Read, Golo Ahlenstiel · 2021 · Livers
81. Protozoan‐Derived Cytokine‐Transgenic Macrophages Reverse Hepatic Fibrosis
    Chen, Ying, Wang, Jie, Zhou, Nan, Fang, Qi, Cai, Haijian, Du, Zhuoran, An, Ran, Liu, Deng, Chen, Xuepeng, Wang, Xinxin et al. · 2024 · Advanced Science
82. A Genetically Engineered Biomimetic Nanodecoy for the Treatment of Liver Fibrosis
    Yang Du, Hao Ding, Yining Chen, Bingqiang Gao, Zhengwei Mao, Weilin Wang, Yuan Ding · 2024 · Advanced Science
83. Characterization of diseased primary human hepatocytes in an all-human cell-based triculture system
    Justin J. Odanga, Sharon M. Anderson, Erick K. Breathwaite, Sharon Collins Presnell, Edward L. LeCluyse, Jingsong Chen, Jessica R. Weaver · 2024 · Scientific Reports
84. Identifying Molecular Targets to Improve Immune Function in Alcoholic Hepatitis
    Ramon A. Bataller, Pranoti Mandrekar · 2015 · Gastroenterology
85. New insights into combined immunotherapy for hepatocellular carcinoma associated with liver cirrhosis
    Yufan Liu, Kexin Cong, Qiao Li, Dan Zhang, Jiyao Sheng · 2025 · Frontiers in Immunology
86. A microenvironment responsive nanoparticle regulating osteoclast fate to promote bone repair in osteomyelitis
    Huan Zeng, Dize Li, Qingqing He, Xinhui Zheng, Xu Chen, Guangyu Jian, Hongmei Zhang, Tao Chen · 2025 · Materials Today Bio
87. Macrophage p38 kinase inhibition for liver regeneration
    Klaus Schulze‐Osthoff, Heike Bantel · 2017 · FEBS Journal
88. sTim-3 alleviates liver injury via regulation of the immunity microenvironment and autophagy
    Ying Yang, Gaoxiang Ying, Fengtian Wu, Zhi Chen · 2020 · Cell Death Discovery
89. Mitigation of portal fibrosis and cholestatic liver disease in ANKS6 ‐deficient livers by macrophage depletion
    Merlin Airik, Blake T. McCourt, Tugba Tastemel Ozturk, Amy B. Huynh, Xiaoyi Zhang, Justin T. Tometich, Rezan Topaloğlu, Hasan Ozen, Diclehan Orhan, Kari Nejak‐Bowen et al. · 2022 · The FASEB Journal
90. Anti-inflammatory and immunomodulating effects of rilpivirine: Relevance for the therapeutics of chronic liver disease
    Ángela B. Moragrega, Aleksandra Gruevska, Isabel Fuster‐Martínez, Ana M. Benedicto, Joan Tosca-Cuquerella, Cristina Montón, Víctor M. Víctor, Juan Vicente Esplugues, Ana Blas‐García, Nadezda Apostolova · 2023 · Biomedicine & Pharmacotherapy
91. Proteomic-genomic adjustments and their confluence for elucidation of pathways and networks during liver fibrosis
    Hadiya Husain, Riaz Ahmad, Anish Khan, Inamuddin Inamuddin, Abdullah Mohamed Asiri · 2018 · International Journal of Biological Macromolecules
92. Src kinase as a potential therapeutic target in non‐alcoholic and alcoholic steatohepatitis
    Dhadhang Wahyu Kurniawan, Richell S. Booijink, Arun Kumar Jajoriya, Garima Dhawan, Divya Mishra, Dorenda Oosterhuis, Josepmaria Argemí, Gert Storm, Peter Olinga, Ramon A. Bataller et al. · 2022 · Clinical and Translational Discovery
93. YKL-40 promotes chemokine expression following drug-induced liver injury via TF-PAR1 pathway in mice
    Zhan Jing-Lun, Chai Shuang, Limei Zhao, Xiaodong Liu · 2023 · Frontiers in Pharmacology
94. A Network Pharmacology Approach to Explore the Mechanisms of Artemisiae scopariae Herba for the Treatment of Chronic Hepatitis B
    Asi He, Wei Wang, Xia Yang, Xiaoping Niu · 2021 · Evidence-based Complementary and Alternative Medicine
95. Determination of M1/M2 Macrophage Polarization in Ipsilateral and Contralateral Rat Testis Tissue Following Unilateral Torsion/Detorsion
    Merve Kavak Balgetir, Nalan Kaya Tektemur, Ahmet Tektemur, Gaffari Türk, İbrahim Halil Güngör, Aslıhan Çakır Cihangiroğlu, Ramazan Fazıl Akkoç, Tuncay Kuloğlu, Dürrin Özlem Dabak · 2024 · Reproductive Sciences
96. Recent insights into contributing factors in the pathogenesis of cirrhotic ascites
    Zhen Li, Junfeng Zhu, Hao Ouyang · 2024 · Frontiers in Medicine
97. Crosstalk between Hepatic Stellate Cells and Hepatic Macrophages in Metabolic Dysfunction–Associated Steatohepatitis
    Haoran Zhong, Chen Liu, Zhiwei Huang, Peng Tan, Hao Chen, Wenguang Fu · 2025 · American Journal Of Pathology
98. Bioluminescence imaging of mouse monocyte chemoattractant protein-1 expression in inflammatory processes
    Fangyang Shao, Lei Ci, Jiahao Shi, Fei Fang, Bowen Yan, Xijun Liu, Xiangyu Yao, Mengjie Zhang, Hua Yang, Zhugang Wang et al. · 2022 · Acta Biochimica et Biophysica Sinica
99. Increased plasma levels of monocyte chemoattractant protein‐1 in patients with hepatitis B virus pre‐S2 gene deletion mutation predict a higher risk of hepatocellular carcinoma recurrence after curative surgical resection
    Long‐Bin Jeng, Tsai‐Chung Li, John C. K. Wang, Chiao‐Fang Teng · 2023 · Cancer
100. Update on the role of Chemokines and Chemokine Receptors in Liver Fibrosis
     Hui Li · 2023 · Journal of Gastrointestinal and Liver Diseases